According to The Insight Partners market research study of “Middle East and Africa Typhoid Fever Vaccines Market Forecast to 2027 - Covid-19 Impact and Analysis by Vaccine Type and Route Of Administration,” Middle East and Africa typhoid fever vaccines market is projected to reach US$ 37.09 million in 2027 from US$ 20.00 million in 2019. The market is estimated to grow at CAGR of 8.3% from 2020 to 2027. The report highlights trends prevailing in the Middle East and Africa typhoid fever vaccines market and the factors driving market along with those that act as hindrances.
The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.
Middle East and Africa typhoid fever vaccines market is expected to grow owing to growing initiatives for typhoid fever in Middle East and Africa region. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Middle East and Africa typhoid fever vaccines market are includes GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., Sanofi, Pax Vax Inc, BHARAT BIOTECH among others.
The report segments Middle East and Africa Typhoid Fever Vaccines market as follows:
By Vaccine Type
- Live Attenuated Vaccine
- Capsular Polysaccharide Vaccines
- Conjugate Vaccine
- Others
By Route of Administration
- Oral
- Injectable
By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East and Africa
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com